January 23, 2018
Alexion Pharmaceuticals refreshes its board of directors
Alexion Pharmaceuticals has welcomed Deborah Dunsire, M.D. as the company’s Board of Directors new independent director.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Approval
January 23, 2018
Arena Pharmaceuticals to host talks about treatment of autoimmune diseases
Arena Pharmaceuticals ARNA), today announced that it will host a key opinion leader (KOL) event for investors focused on sphingosine-1-phosphate…
January 22, 2018
Novartis buys French radiopharmaceutical company AAA for $3.9 billion
Novartis Group France has completed a tender to buy Advanced Accelerator Applications S.A. for $3,9 billion, or $41.00 per ordinary…
January 22, 2018
Silence Therapeutics nets important patent in Europe
Silence Therapeutics strengthen the protection for its innovative chemical modification technology in Europe, as the European Patent Office granted it…
January 22, 2018
Celgene Corporation to acquire Juno Therapeutics, building global leadership in cellular immunotherapy
Celgene Corporation will acquire Juno Therapeutics, it has been announced as the two companies have signed a merger agreement.
January 22, 2018
European Commission OK’s BMS’s Yervoy for children with unresectable or metastatic melanoma
In addition to today’s news about Yervoy in combination with Opdivo , Bristol-Myers Squibb said today that the European Commission (EC) has…
January 22, 2018
BMS says Opdivo and Yervoy benefitial for patients with certain metastatic colorectal cancer
Bristol-Myers Squibb Company today said that new data from a cohort of the phase 2 CheckMate -142 test of the…
January 19, 2018
Bavarian Nordic kicks-off cancer candidate trial
Bavarian Nordic said Friday that it has kicked off a clinical trial of BN-Brachyury, a novel cancer immunotherapy candidate designed…
January 19, 2018
AstraZeneca does business in Japan, another approval today, for Fasenra
AstraZeneca and its global biologics research and development arm, MedImmune, said on Friday that the Japanese Ministry of Health, Labour…
January 19, 2018
AZ’s Lynparza approved in Japan for the treatment of advanced ovarian cancer
AstraZeneca and Merck have announced that the Japanese Ministry of Health, Labour and Welfare has approved Lynparza (olaparib) tablets (300mg…